R&D channel feed – Endpoints News

R&D channel feed

GSK ends PhIII Zejula trial after running into challenges enrolling patients

3 years ago

Roche's Q1 pipeline cleanup claims PhII myelofibrosis drug, early-stage MAGE-A4 work

3 years ago

With proxy fight deadline a month away, Illumina announces plans to cut $100M in costs

3 years ago

Biogen CEO in search for 'external growth' to boost pipeline as revenue falls

3 years ago

MarketingRx roundup: HHS' Covid campaign continues as health emergency end nears; Pharmas celebrate Earth Day

3 years ago

Ideaya goes forward with $150M offering after touting PhII cancer data

3 years ago

‘Dawn of oral therapy’: Morphic touts UC data in march toward Takeda’s Entyvio

3 years ago

Updated: Novartis trims pipeline by 10% as Vas Narasimhan places premium on 'high-value medicines'

3 years ago

Updated: Biogen chops certain stroke and RNA therapy programs as it continues R&D revamp

3 years ago

Florida-based biotech with approved cardiovascular therapy moves to go public via SPAC

3 years ago

Boehringer Ingelheim kicks off €350M R&D center in Germany

3 years ago

Applied Therapeutics says rare disease drug fails PhIII trial, still plans to seek approval

3 years ago

4D Molecular Therapeutics acquires eye disease asset from Fortress Biotech subsidiary

3 years ago

Lilly will test its weight loss drug directly against Novo Nordisk's Wegovy

3 years ago

On Vertex and CRISPR Therapeutics’ heels, bluebird submits sickle cell gene therapy to FDA

3 years ago

Unity touts PhII win, plots head-to-head with Regeneron drug in 'defining moment'

3 years ago

AstraZeneca, Ionis unveil full PhIII data for 'mega brand' ATTR drug

3 years ago

Apellis’ expansion plans into ALS face roadblock

3 years ago

Analysts expect quiet first quarter as Big Pharma earnings begin to roll in

3 years ago

PharmaEssentia secures $462M+ to further growth of Besremi and its pipeline

3 years ago

Junshi Biosciences touts lung cancer data as it looks to expand PD-1 label in China again

3 years ago

BeiGene notches win for PD-1 drug in stomach cancers. When will partner Novartis submit for approval?

3 years ago

Updated: Indian CDMO opens 'dedicated' R&D site for Schrödinger as part of five-year agreement

3 years ago

AACR roundup: Merus eyes accelerated approval; Immuneering accelerates RAS drug

3 years ago

First page Previous page 87 88 899091 92 93 Next page Last page